Literature DB >> 1453435

Factors affecting the uptake of prenatal diagnosis for sickle cell disease.

M Petrou1, M Brugiatelli, R H Ward, B Modell.   

Abstract

Between 1979 and 1990, 170 couples at risk of having children with sickle cell disease, resident in the UK and with a continuing pregnancy, were referred for counselling at the University College Hospital Perinatal Centre. Approximately 50% of the couples, including those where one partner actually had sickle cell disease, requested prenatal diagnosis. This was requested in 82% of pregnancies when the mother was seen in the first trimester of pregnancy and in 49% when she was seen in the second trimester. More than 90% of referred couples who already had an affected child requested prenatal diagnosis. The type of sickle cell disease involved and ethnic group also influenced choice. These results show the importance of detecting and counselling couples at risk before pregnancy whenever possible.

Entities:  

Mesh:

Year:  1992        PMID: 1453435      PMCID: PMC1016180          DOI: 10.1136/jmg.29.11.820

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  6 in total

1.  Couple screening for cystic fibrosis.

Authors:  N J Wald
Journal:  Lancet       Date:  1991-11-23       Impact factor: 79.321

2.  Pregnant women identified as hemoglobinopathy carriers by prenatal screening want genetic counseling and use information provided.

Authors:  P T Rowley; S Loader; M Walden
Journal:  Birth Defects Orig Artic Ser       Date:  1988

3.  Counselling for prenatal diagnosis of sickle cell disease and beta thalassaemia major: a four year experience.

Authors:  E N Anionwu; N Patel; G Kanji; H Renges; M Brozović
Journal:  J Med Genet       Date:  1988-11       Impact factor: 6.318

4.  First-trimester fetal diagnosis for haemoglobinopathies: three cases.

Authors:  J M Old; R H Ward; M Petrou; F Karagözlu; B Modell; D J Weatherall
Journal:  Lancet       Date:  1982-12-25       Impact factor: 79.321

5.  First-trimester fetal diagnosis for haemoglobinopathies: report on 200 cases.

Authors:  J M Old; A Fitches; C Heath; S L Thein; D J Weatherall; R Warren; C McKenzie; C H Rodeck; B Modell; M Petrou
Journal:  Lancet       Date:  1986-10-04       Impact factor: 79.321

6.  Antenatal diagnosis of thalassaemia major.

Authors:  D V Fairweather; B Modell; V Berdoukas; B P Alter; D G Nathan; D Loukopoulos; W Wood; J B Clegg; D J Weatherall
Journal:  Br Med J       Date:  1978-02-11
  6 in total
  5 in total

1.  A multidisciplinary approach for improving services in primary care: randomised controlled trial of screening for haemoglobin disorders.

Authors:  M Modell; B Wonke; E Anionwu; M Khan; S S Tai; M Lloyd; B Modell
Journal:  BMJ       Date:  1998-09-19

2.  Psychosocial and clinical burden of thalassaemia intermedia and its implications for prenatal diagnosis.

Authors:  S Ratip; D Skuse; J Porter; B Wonke; A Yardumian; B Modell
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

Review 3.  Who should be offered genetic screening?

Authors:  M Super
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

4.  Prenatal genetic counseling for hemoglobinopathy carriers: a comparison of primary providers of prenatal care and professional genetic counselors.

Authors:  P T Rowley; S Loader; C J Sutera; A Kozyra
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

5.  Offering antenatal sickle cell and thalassaemia screening to pregnant women in primary care: a qualitative study of women's experiences and expectations of participation.

Authors:  Vicki Tsianakas; Karl Atkin; Michael W Calnan; Elizabeth Dormandy; Theresa M Marteau
Journal:  Health Expect       Date:  2011-03-03       Impact factor: 3.377

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.